David Horovitz1, Yifan Meng2, Jean V Joseph1, Changyong Feng3, Guan Wu1, Hani Rashid1, Edward M Messing1. 1. Department of Urology, University of Rochester Medical Centre; Rochester, NY, United States. 2. School of Medicine and Dentistry, University of Rochester; Rochester, NY, United States. 3. Department of Biostatistics and Computational Biology, University of Rochester Medical Centre; Rochester, NY, United States.
Abstract
INTRODUCTION: We sought to determine the value of obtaining preoperative urinary cytology when diagnostic workup of an upper tract mass is suspicious for upper tract urothelial carcinoma (UTUC), but biopsy fails to confirm the diagnosis. METHODS: Using billing code data, 239 patients were identified as having undergone radical nephroureterectomy (RNU) by 16 urologists from September 29, 1998 to July 31, 2015. Of this group, 19 adult patients had a presumed preoperative diagnosis of UTUC in a native kidney, at least three months of followup, no history of concurrent radical cystectomy with RNU, and negative/non-diagnostic tissue biopsy. These patients were divided into three groups: Group A had no urinary cytology taken (n=6); Group B had upper and/or lower tract cytology performed with neither positive nor atypical (n=7); Group C had upper and/or lower tract cytology performed with at least one positive or atypical (n=6). RESULTS: Demographic information and diagnostic workup was similar between the groups, although Group A had more patients with a history of prior radical cystectomy for bladder cancer (p=0.02). One patient in Group B had benign tissue on final pathology. All patients in Groups A and C had malignancy on final pathology and overall, the three groups had similar rates of malignancy. CONCLUSIONS: When a composite of clinical findings suggest UTUC, performing urinary cytology may not be necessary. A negative result in this setting should not be used to rule out UTUC, as this is often discordant with final pathology. A positive cytology result may help solidify the diagnosis when other findings are less clear.
INTRODUCTION: We sought to determine the value of obtaining preoperative urinary cytology when diagnostic workup of an upper tract mass is suspicious for upper tract urothelial carcinoma (UTUC), but biopsy fails to confirm the diagnosis. METHODS: Using billing code data, 239 patients were identified as having undergone radical nephroureterectomy (RNU) by 16 urologists from September 29, 1998 to July 31, 2015. Of this group, 19 adult patients had a presumed preoperative diagnosis of UTUC in a native kidney, at least three months of followup, no history of concurrent radical cystectomy with RNU, and negative/non-diagnostic tissue biopsy. These patients were divided into three groups: Group A had no urinary cytology taken (n=6); Group B had upper and/or lower tract cytology performed with neither positive nor atypical (n=7); Group C had upper and/or lower tract cytology performed with at least one positive or atypical (n=6). RESULTS: Demographic information and diagnostic workup was similar between the groups, although Group A had more patients with a history of prior radical cystectomy for bladder cancer (p=0.02). One patient in Group B had benign tissue on final pathology. All patients in Groups A and C had malignancy on final pathology and overall, the three groups had similar rates of malignancy. CONCLUSIONS: When a composite of clinical findings suggest UTUC, performing urinary cytology may not be necessary. A negative result in this setting should not be used to rule out UTUC, as this is often discordant with final pathology. A positive cytology result may help solidify the diagnosis when other findings are less clear.
Authors: Julia Straub; Frank Strittmatter; Alexander Karl; Christian G Stief; Stefan Tritschler Journal: Urol Oncol Date: 2012-01-31 Impact factor: 3.498
Authors: Jamie Messer; Shahrokh F Shariat; James C Brien; Michael P Herman; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Robert G Uzzo; Mark Wille; Scott E Eggener; Gary Steinberg; John D Terrell; Steven M Lucas; Yair Lotan; Stephen A Boorjian; Jay D Raman Journal: BJU Int Date: 2011-02-14 Impact factor: 5.588
Authors: E F Sverrisson; T Kim; P N Espiritu; W J Sexton; J M Pow-Sang; J Dhillon; P E Spiess Journal: Int Braz J Urol Date: 2014 Jul-Aug Impact factor: 1.541
Authors: M Jovanovic; I Soldatovic; A Janjic; A Vuksanovic; Z Dzamic; M Acimovic; J Hadzi-Djokic Journal: Urol Int Date: 2011-08-24 Impact factor: 2.089